-
The October newsletter announced the graduation of the novel polyclonal antibody therapy, SAB-185 to the phase 3 study of ACTIV-2…
-
The September newsletter announced the positive data for the monoclonal antibody combination therapy BRII196/BRII-198 from the ACTIV-2 study. The newsletter…
-
The August newsletter announced the launch of study A5391, the DoIT Study. The newsletter also announced the solicitation for ACTG…
-
The July newsletter features the announcement of the publication of study A5349 in the New England Journal of Medicine as…
-
The June newsletter features a special statement from ACTG Network Leadership honoring the 40th anniversary of the initial publication of…
-
The May newsletter features a tribute to CAB member Raymond Allmond, who passed away last month. Also included are the…
-
The April Newsletter announced the decision to hold this year’s Annual Meeting virtually. It also featured publications for studies A5315,…
-
The March newsletter features summaries for the 24 ACTG abstracts to be presented at CROI 2021. It also features the…
-
This month the ACTG faced unprecedented losses of members of our community, Drs. John G Bartlett and David Katzenstein, Professor…
-
Letters from Drs. Currier and Eron, as well as Orbit Clanton and Estere Mutero, to bring the network into the…
-
The December Newsletter is a look back on the progress we have made over the past year in HIV research.…
-
The November Newsletter announces the incredible findings of study A5349 regarding a shortened 4-month regimen for the treatment of drug-susceptible…
HANC NEWSLETTER
Check Out News From The Office Of HIV/AIDS Network Coordination (HANC)